Cargando…

Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)

Acute myeloid leukemia (AML) is a malignant hematological tumor with disordered oncogenes/tumor suppressor genes and limited treatments. The potent anti-cancer effects of bromodomain and extra-terminal domain (BET) inhibitors, targeting the key component of super enhancers, in early clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Ziyang, Shu, Yi, Wang, Jinxia, Wang, Chunxia, Feng, Tienan, Yang, Li, Shao, Jingbo, Zou, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485276/ https://www.ncbi.nlm.nih.gov/pubmed/36157504 http://dx.doi.org/10.1016/j.gendis.2022.01.006

Ejemplares similares

Chromosomal rearrangements in acute myeloid leukemia (AML)
por: Belloni, E, et al.
Publicado: (2010)

New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020)

AngioCRIME in Acute Myeloid Leukemia (AML)
por: Macintyre, Elizabeth
Publicado: (2017)

Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

Corrigendum: Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)

New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020)

A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
por: Zhao, Chunxia, et al.
Publicado: (2021)

The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML)
por: Assouline, Sarit, et al.
Publicado: (2012)

Super-enhancer-associated gene CAPG promotes AML progression
por: Ma, Qian, et al.
Publicado: (2023)

Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
por: Qin, Lijun, et al.
Publicado: (2015)

Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?
por: Yilmaz, Musa, et al.
Publicado: (2019)

Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
por: Winer, Eric S., et al.
Publicado: (2019)

Switch of the mutation type of the NPM1 gene in acute myeloid leukemia (AML): relapse or secondary AML?
por: Webersinke, G, et al.
Publicado: (2014)

Acute Myeloid Leukemia (AML) with Erythroid Predominance Exhibits Clinical and Molecular Characteristics that Differ from Other Types of AML
por: Zuo, Zhuang, et al.
Publicado: (2012)

Integrated N- and O-Glycomics of Acute Myeloid Leukemia (AML) Cell Lines
por: Blöchl, Constantin, et al.
Publicado: (2021)

Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML)
por: Hofmann, Susanne, et al.
Publicado: (2019)

Mediator Kinase Inhibition Further Activates Super-Enhancer Associated Genes in AML
por: Pelish, Henry E., et al.
Publicado: (2015)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
por: Guolo, Fabio, et al.
Publicado: (2022)

Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
por: Skopek, Rafał, et al.
Publicado: (2023)

Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
por: Matre, Polina, et al.
Publicado: (2016)

The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML)
por: Yan-Fang, Tao, et al.
Publicado: (2013)

Securinine, a Myeloid Differentiation Agent with Therapeutic Potential for AML
por: Gupta, Kalpana, et al.
Publicado: (2011)

Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
por: Stevens, Alexandra McLean, et al.
Publicado: (2023)

Targeting Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML): Moving beyond Prognostication
por: Tiong, Ing S., et al.
Publicado: (2023)

Chemotherapy as Treatment for Acute Myeloid Leukemia (AML)-Induced Facial Nerve Palsy
por: Fana, Michael, et al.
Publicado: (2022)

A new approach in acute myeloid leukemia (AML): Samatya-predicting score
por: Serin, Istemi, et al.
Publicado: (2022)

Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML)
por: Demircan, Muhammed Burak, et al.
Publicado: (2022)

The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (AML)?
por: Haghi, Atousa, et al.
Publicado: (2022)

P478: MOLECULAR CHARACTERIZATION OF EXTRAMEDULLARY LOCALIZATIONS IN ACUTE MYELOID LEUKEMIA (AML)
por: Silvestrini, Giorgia, et al.
Publicado: (2023)

Super-enhancers and novel therapeutic targets in colorectal cancer
por: Liu, Qian, et al.
Publicado: (2022)

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
por: Fang, Fang, et al.
Publicado: (2022)

Chronic myeloid leukemia blast crisis presented with AML of t(9;22) and t(3;14) mimicking acute lymphocytic leukemia
por: Liu, Keyu, et al.
Publicado: (2019)

Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia
por: Kiehlmeier, Sandra, et al.
Publicado: (2021)

P1686: LONG-TERM COMORBIDITY AND HEALTH PROBLEMS IN ACUTE MYELOID LEUKEMIA (AML) SURVIVORS: AN INTERNATIONAL AML SURVIVORSHIP STUDY
por: Efficace, Fabio, et al.
Publicado: (2023)

Identification of Survival-Related Genes in Acute Myeloid Leukemia (AML) Based on Cytogenetically Normal AML Samples Using Weighted Gene Coexpression Network Analysis
por: Chen, Tingting, et al.
Publicado: (2022)

Prognostic prediction of novel risk scores (AML-DRG and AML-HCT-CR) in acute myeloid leukemia patients with allogeneic hematopoietic stem cell transplantation
por: Cao, Weijie, et al.
Publicado: (2022)

Identification of Protein Biomarker Signatures for Acute Myeloid Leukemia (AML) Using Both Nontargeted and Targeted Approaches
por: Dowling, Paul, et al.
Publicado: (2021)

Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy
por: Golubeva, Diana, et al.
Publicado: (2023)

Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
por: Tang, Ruoping, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_40fq34uct1lptnv2m9c2ru2kl1